$15.79
0.191.22%
Last update: Nov 9, 4:00 PM
Yarrow Bioscience Inc
YARWNASDAQ
The average analyst price target for Yarrow Bioscience is $59, 273.7% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $58 to $60. The latest change came on Nov 6, 2026, when Guggenheim initiated coverage of Yarrow Bioscience with a Buy rating and a $60 price target.
Price Target Range — 2 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
